From:  Understanding doxorubicin associated calcium remodeling during triple-negative breast cancer treatment: an in silico study

Readout values and 90% CI for four different parametric conditions

CategoriesPeak amplitude (μM)Peak width (s)AUC
Control0.3033, [0.3026, 0.3040]26.2439, [26.2257, 26.2953]25.1919, [25.1898, 25.2481]
Doxo 10.3180, [0.3173, 0.3187]24.0503, [24.0322, 24.1164]27.3215, [27.3201, 27.3930]
Doxo 20.3292, [0.3285, 0.3300]21.3144, [21.3128, 21.3882]29.3102, [29.3042, 29.3838]
Doxo 30.3381, [0.3373, 0.3390]19.2799, [19.2700, 19.3436]31.1513, [31.1452, 31.2368]
Return to article view